Chewable DGL

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Glycyrrhiza glabra, Quantity: 400 mg (Equivalent: Glycyrrhiza glabra, Qty 4 g)

Disponible depuis:

Factors Group Australia Pty Ltd

forme pharmaceutique:

Tablet, chewable

Composition:

Excipient Ingredients: silicon dioxide; magnesium stearate; stearic acid; Aniseed Powder; microcrystalline cellulose; xylitol; Stevia rebaudiana

Mode d'administration:

Oral

indications thérapeutiques:

Anti-inflammatory/relieve inflammation ; Demulcent/soothe irritated tissues ; Decrease/reduce/relieve abdominal pain/discomfort ; Decrease/reduce/relieve symptoms of heartburn ; Helps decrease/reduce/relieve mild gastrointestinal tract inflammation ; Expectorant/clear respiratory tract mucous ; Loosen respiratory tract mucous ; Decrease/reduce/relieve throat mucous membrane irritation/inflammation

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Listed

Date de l'autorisation:

2019-07-31